Emerging Mass Tort Claims to Watch in 2027

Mass tort litigation moves in waves, and the cases gaining momentum today will define the legal landscape of 2027. For individuals harmed by defective products, toxic exposures, or corporate negligence, understanding which claims are rising matters far beyond academic curiosity: it determines whether you recognize your own eligibility before a filing deadline passes. The coming year promises a crowded docket of consolidated actions, from incretin-based diabetes and weight-loss drugs to forever chemicals in firefighting foam, and the claimants who act early tend to fare better than those who wait. This overview examines the emerging mass tort claims to watch in 2027, explains how a mass tort matures from scattered lawsuits into a coordinated proceeding, and shows how platforms like FormsByLawyers organize claimant information so that people facing serious injuries can request a no-cost case review without navigating the maze alone.

How a Mass Tort Becomes Established (and Why 2027 Matters)

A mass tort begins as a pattern. Individual plaintiffs file separate lawsuits, often in different states, alleging similar harm from a common product or conduct. As filings accumulate, courts and litigants look for efficiencies: cases may be consolidated before a single judge through multidistrict litigation, grouped in a state court coordination, or pursued as a class action when common questions dominate. The distinction matters to claimants, and our guide on mass tort versus class action explains why mass torts typically preserve individual damage claims while class actions resolve them collectively.

What makes 2027 a pivotal year is the maturation timeline. Litigation that began in the early 2020s is now reaching the phases where science, discovery, and bellwether trials clarify whether a claim has legs. When early trial results favor plaintiffs, settlement pressure builds and claim pools expand. When they do not, some actions narrow. Either way, the window for filing does not stay open indefinitely, and the cases below are at or near the stage where deadlines begin to harden.

Eligibility assessment follows a similar pattern across these matters. Claimants generally need to show three things: exposure to the product or substance, a diagnosis or injury consistent with the alleged harm, and documentation linking the two. The strength of that documentation, medical records, prescription histories, employment records, or proof of residence near a contamination site, often determines how quickly a claim can be evaluated. Attorneys use these materials to screen cases, and claimants who gather them early avoid the scramble that comes when a settlement program opens.

Pharmaceutical and Medical Device Litigation Gaining Momentum

Drug and device cases dominate the emerging mass tort claims to watch in 2027, largely because prescription records create unusually clear exposure trails. GLP-1 receptor agonists, the class of medications marketed for diabetes and weight loss, face growing scrutiny over gastrointestinal injuries such as gastroparesis and bowel obstruction. With millions of users and active marketing, the potential claimant pool is enormous, and courts are already wrestling with how to coordinate the claims.

Hernia mesh litigation continues to mature, with thousands of cases alleging that certain mesh products caused infection, adhesion, or the need for revision surgery. Talcum powder claims remain active as well, and the science linking talc to ovarian cancer and mesothelioma has been tested in multiple trials. Tylenol and autism or ADHD claims represent a newer frontier, focusing on prenatal exposure, and the litigation is still in early phases where causation evidence is being developed.

Other device and drug matters rounding out the watch list include:

• Bard PowerPort catheter claims alleging fracture, migration, or infection
• Phillips CPAP and BiPAP machine claims involving foam degradation and respiratory injury
• Mounjaro and similar incretin drug claims overlapping with the broader GLP-1 litigation
• NEC baby formula claims involving premature infants and severe gastrointestinal disease

Each of these matters carries its own eligibility criteria and procedural posture. The common thread is that 2027 will bring more bellwether trials, more settlement discussions, and more pressure on claimants to decide whether to file. Because these cases involve medical causation, the quality of a claimant's medical records often matters more than the number of defendants named, and early screening by a qualified attorney can reveal whether a claim is viable.

Environmental and Toxic Exposure Claims on the Rise

Environmental mass torts are expanding in scope and ambition. AFFF firefighting foam litigation, centered on per- and polyfluoroalkyl substances known as PFAS, has become one of the largest consolidated actions in the country, with claims from firefighters, military personnel, and residents of contaminated communities. The science on PFAS health effects, including links to certain cancers and thyroid disease, continues to develop, and 2027 will see further trials and settlement activity.

Paraquat weed killer litigation alleges a connection between the herbicide and Parkinson's disease, a devastating neurological condition. Camp Lejeune water contamination claims, brought under a federal statute, involve veterans and family members exposed to contaminated drinking water at the North Carolina base. These matters share a feature that distinguishes them from product cases: proof of exposure often depends on where someone lived or worked, which makes documentation of residency, employment, and military service critical.

For claimants in environmental cases, the timeline is especially unforgiving. Many statutes of limitation run from the date of diagnosis rather than the date of exposure, but some programs impose their own filing windows. A claimant who learns of a diagnosis in 2026 may have only a limited period to act, and the emerging mass tort claims to watch in 2027 include several matters where the first major filing deadlines will arrive.

Why Filing Deadlines Differ Across Cases

One of the most common misconceptions about mass torts is that there is a single national deadline. In reality, deadlines vary by state, by claim type, and by the procedural mechanism used to resolve the litigation. Statutes of limitation and statutes of repose set outer limits that differ from jurisdiction to jurisdiction, and courts presiding over consolidated actions sometimes set case management deadlines that apply only to claimants who have registered or filed.

Settlement programs add another layer. When a defendant agrees to resolve claims, the agreement typically establishes a claims period with a start and end date, and claimants who miss it may be barred even if their underlying lawsuit would have been timely. This is why monitoring the procedural posture of each matter matters as much as knowing the injury. A claim that is strong on the merits can still fail if it is filed after the window closes.

The practical takeaway is that anyone who suspects they have a claim should not wait for a deadline to appear in headlines. Consulting an attorney early allows time to gather records, assess eligibility, and file before any bar date. For people injured in traffic collisions, the same urgency applies in ordinary personal injury matters, and resources such as CarInjuryAccident connect crash victims with attorneys who handle those claims. Mass tort claimants face a different but equally real clock, and the safest approach is to treat every potential deadline as nearer than it appears.

How FormsByLawyers Organizes Mass Tort Claimant Information

FormsByLawyers is a legal resources platform, not a law firm, and it does not provide legal advice or endorse specific attorneys. What it does offer is structure for people facing complex claims. The platform's mass tort resources group claims by category, from talcum powder and hernia mesh to NEC baby formula, Camp Lejeune, Phillips CPAP machines, Paraquat, AFFF firefighter foam, Tylenol ADHD and autism, Bard PowerPort catheters, and Mounjaro. Each category page explains the nature of the allegations and the kinds of injuries associated with the matter, giving claimants a starting point for understanding whether their situation fits.

From there, the platform's tools help claimants move from information to action. Quick Quotes provide a rapid assessment of a legal need, while Customized Quotes tailor the response to a specific situation. The patented attorney selection process identifies the top five percent of attorneys annually based on peer influence and research, and users can request a free, confidential, no-obligation case review. Submitting information does not create an attorney-client relationship, but it does start a conversation that can clarify eligibility and timing.

For legal professionals, the same infrastructure supports lead generation, connecting attorneys and law firms with individuals who are actively seeking help. That dual function is why the platform can organize claimant information at scale: the categories, quote tools, and review process are built to handle volume while keeping each inquiry tied to a specific claim type. The result is a resource that helps claimants avoid the two most common mistakes in mass tort litigation, filing in the wrong forum and filing too late.

Practical Steps for Potential Claimants

If you believe you may be affected by one of the emerging mass tort claims to watch in 2027, the first step is documentation. Gather medical records, prescription histories, employment records, military service records, and any proof of residence that could establish exposure. The second step is a case review with a qualified attorney who can evaluate the strength of the claim and explain the applicable deadlines.

It also helps to understand the difference between a mass tort and a class action before deciding how to proceed, because the two structures offer different levels of individual control over the outcome. Claimants in mass torts typically retain their own counsel and pursue individual damages, while class members are bound by a collective resolution unless they opt out. Knowing which structure applies to a given matter prevents surprises later.

Finally, treat deadlines as real. The cases gaining attention in 2027 will not wait for claimants who are still deciding. Early action preserves options, and the cost of a no-obligation review is nothing compared with the cost of a missed filing window. Whether the matter involves a prescription drug, a medical device, a contaminated water supply, or a consumer product, the same principle holds: information plus timing equals opportunity.

The mass tort landscape of 2027 will reward claimants who pay attention now. From GLP-1 drugs and hernia mesh to PFAS foam and Camp Lejeune water claims, the matters gaining momentum today will shape settlements and trials for years to come. Understanding how these cases mature, why deadlines differ, and how platforms like FormsByLawyers organize claimant information gives individuals a genuine advantage. The first step costs nothing and can be taken today: request a free case review, gather your records, and let a qualified attorney assess whether your claim belongs among the emerging mass torts of 2027.